US Patent Issued to VANDERBILT UNIVERSITY, THE SCRIPPS RESEARCH INSTITUTE on Dec. 16 for "Peptide vaccine based on a new universal influenza a hemagglutinin head domain epitope and human monoclonal antibodies binding thereto" (California, Tennessee Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,336, issued on Dec. 16, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.) and THE SCRIPPS RESEARCH INSTITUTE (La Jolla, Calif.).

"Peptide vaccine based on a new universal influenza a hemagglutinin head domain epitope and human monoclonal antibodies binding thereto" was invented by James E. Crowe Jr. (Nashville, Tenn.), Xiaozhen Hu (San Diego) and William Schief (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to peptide antigens derived from a previously undefined epitope on influenza A virus hemagglutinin and methods for use thereof."

The patent was filed on May 16, 2020, under Application...